Products Categories
| CAS No.: | 51037-30-0 |
|---|---|
| Name: | Acipimox |
| Article Data: | 14 |
| Molecular Structure: | |
|
|
|
| Formula: | C6H6N2O3 |
| Molecular Weight: | 154.125 |
| Synonyms: | 5-Methyl-2-pyrazincarbonsaeure-4-oxid;2-Pyrazinecarboxylic acid, 5-methyl-, 4-oxide;4-Oxide-5-methylpyrazine-2-carboxylic acid;Acipimox (5-Methylpyrazinecarboxylic acid 4-oxide);Acipimox [BAN:INN];5-Methylpyrazinecarboxylic acid 4-oxide;K 9321;6-methyl-1-oxido-pyrazine-2-carboxylic acid;Pyrazinecarboxylic acid,5-methyl-,4-oxide;Acipimoxum [INN-Latin]; |
| EINECS: | 256-928-3 |
| Density: | 1.44 g/cm3 |
| Melting Point: | 177-180 °C |
| Boiling Point: | 539 °C at 760 mmHg |
| Flash Point: | 279.8 °C |
| Appearance: | low yellow liquid or crystalline |
| Hazard Symbols: |
 Xi
|
| Risk Codes: | 36 |
| Safety: | 26 |
| PSA: | 75.65000 |
| LogP: | 0.51670 |
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 68439-39-4Poly(oxy-1,2-ethanediyl), alpha-(2-ethylhexyl)-omega-hydroxy-,
- 852475-26-4MC1568
- 958254-66-51H-Imidazo[4,5-b]pyridine-2-carboxaldehyde, 1-methyl-, hydrochloride
- 99170-93-1N-Methyl-2-oxazolamine
- 717878-06-31-(4-fluorophenyl)-4-nitro-1H-imidazole
- 914458-26-7[5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-Methanone
What can I do for you?
Get Best Price
Chemistry
.jpg)
IUPAC Name: 5-Methyl-4-oxidopyrazin-4-ium-2-carboxylic acid
Molecular Formula: C6H6N2O3
Molecular Weight: 154.12 g/mol
Canonical SMILES: c1n(c(cnc1C(=O)O)C)=O
InChI: InChI=1/C6H6N2O3/c1-4-2-7-5(6(9)10)3-8(4)11/h2-3H,1H3,(H,9,10)
EINECS: 256-928-3
Classification Code: Antilipemic agents; Antimetabolites; Drug / Therapeutic Agent
Product Categories: Pyrazine
Melting Point: 177-180 °C
Storage temperature: 2-8 °C
Index of Refraction: 1.608
Molar Refractivity: 37.02 cm3
Molar Volume: 107 cm3
Polarizability: 14.67×10-24 cm3
Surface Tension: 57.4 dyne/cm
Density: 1.44 g/cm3
Flash Point: 279.8 °C
Enthalpy of Vaporization: 85.92 kJ/mol
Boiling Point: 539 °C at 760 mmHg
Vapour Pressure of Acipimoxum (CAS NO.51037-30-0): 1.88E-12 mmHg at 25 °C
Uses
Acipimoxum (CAS NO.51037-30-0) is used in low doses and may have less marked adverse effects,although it is unclear whether the recommended dose is as effective as are standard doses of nicotinic acid .
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | oral | 3500mg/kg (3500mg/kg) | European Journal of Medicinal Chemistry--Chimie Therapeutique. Vol. 15, Pg. 157, 1980. |
Safety Profile
Hazard Codes: 
Xi
Risk Statements: 36
R36: Irritating to eyes.
Safety Statements: 26
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
RTECS of Acipimoxum (CAS NO.51037-30-0): UQ2453000
Specification
Acipimoxum (CAS NO.51037-30-0), its Synonyms are 5-Methyl-2-pyrazincarbonsaeure-4-oxid ; 5-Methyl-2-pyrazinecarboxylic acid 4-oxide ; Acipimox ; 2-Pyrazinecarboxylic acid, 5-methyl-, 4-oxide ; Pyrazinecarboxylic acid, 5-methyl-, 4-oxide .